Jubilant Pharmova has reported results for first quarter ended June 30, 2024 (Q1FY25).
The company has reported net loss at Rs 10.20 crore for the quarter ended June 30, 2024 as compared to net profit of Rs 1.90 crore for the same quarter in the previous year. Total income of the company decreased by 20.18% at Rs 186.20 crore for Q1FY25 as compared to Rs 233.30 crore for the corresponding quarter previous year.
On consolidated basis, the company has reported many fold jump in net profit at Rs 481.80 crore for Q1FY25 as compared to Rs 6.00 crore for the same quarter in the previous year. Total income of the company increased by 9.41% at Rs 1745.70 crore for Q1FY25 as compared to Rs 1595.50 crore for the corresponding quarter previous year.
